CLINICAL_TRIALS
trial_result
· 2020-02-27
Clinical Trial Update: A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial evaluating cardiovascular safety of oral semaglutide in adults with type 2 diabetes has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2020-02-27